相似文献
1
ADME Properties in Drug Delivery.
Pharmaceutics. 2025 May 6;17(5):617. doi: 10.3390/pharmaceutics17050617.
2
The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery.
Pharmaceutics. 2023 Nov 12;15(11):2619. doi: 10.3390/pharmaceutics15112619.
3
Progress in predicting human ADME parameters in silico.
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):251-72. doi: 10.1016/s1056-8719(00)00109-x.
4
Improving early drug discovery through ADME modelling: an overview.
Drugs R D. 2007;8(6):349-62. doi: 10.2165/00126839-200708060-00003.
5
Noncoding microRNAs: small RNAs play a big role in regulation of ADME?
Acta Pharm Sin B. 2012 Apr;2(2):93-101. doi: 10.1016/j.apsb.2012.02.011. Epub 2012 Mar 31.
6
Present and future in vitro approaches for drug metabolism.
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):313-24. doi: 10.1016/s1056-8719(00)00110-6.
7
Current status and future directions of high-throughput ADME screening in drug discovery.
J Pharm Anal. 2020 Jun;10(3):201-208. doi: 10.1016/j.jpha.2020.05.004. Epub 2020 May 23.
8
Recent Progress on Mass Spectrum Based Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Traditional Chinese Medicine.
Curr Drug Metab. 2022;23(2):99-112. doi: 10.2174/1389200223666220211093548.
9
Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection.
Curr Top Med Chem. 2005;5(11):1033-8. doi: 10.2174/156802605774297038.
10
Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Med Chem. 2013 Mar;9(2):163-76. doi: 10.2174/1573406411309020002.
本文引用的文献
1
Construction of humanized CYP1A2 rats using CRISPR/Cas9 to promote drug metabolism and pharmacokinetic research.
Drug Metab Dispos. 2023 Oct 26;52(1):DMD-AR-2023-001500. doi: 10.1124/dmd.123.001500.
2
Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction prediction.
CPT Pharmacometrics Syst Pharmacol. 2022 Dec;11(12):1560-1568. doi: 10.1002/psp4.12870. Epub 2022 Oct 12.
3
CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics.
Acta Pharm Sin B. 2021 Oct;11(10):2973-2982. doi: 10.1016/j.apsb.2021.01.007. Epub 2021 Jan 7.
4
Population pharmacokinetic model selection assisted by machine learning.
J Pharmacokinet Pharmacodyn. 2022 Apr;49(2):257-270. doi: 10.1007/s10928-021-09793-6. Epub 2021 Oct 27.
5
[Epigenetic Regulation of Pharmacokinetic-related Genes in Human Tissues].
Yakugaku Zasshi. 2018;138(11):1391-1396. doi: 10.1248/yakushi.18-00145.
6
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.
AAPS J. 2017 Jan;19(1):26-42. doi: 10.1208/s12248-016-0010-3. Epub 2016 Nov 10.
7
Physiologically based pharmacokinetic (PBPK) modeling in children.
Clin Pharmacol Ther. 2012 Jul;92(1):40-9. doi: 10.1038/clpt.2012.64. Epub 2012 Jun 6.
8
Physiologically based pharmacokinetic (PBPK) models for ethanol.
IEEE Trans Biomed Eng. 2008 Dec;55(12):2691-700. doi: 10.1109/TBME.2008.919132.
Zotero 插件